MP14-19 ARV-766, A PROTAC ANDROGEN RECEPTOR (AR) DEGRADER, COMBINED WITH ABIRATERONE IN NOVEL HORMONAL AGENT (NHA)-NAÏVE METASTATIC PROSTATE CANCER: PHASE 1 COHORT (PART C) OF A PHASE 1/2 STUDY
Shore N, Lang J, Geynisman D, Stewart T, Gao X, Appleman L, Dreicer R, Dorff T, Berghorn E, Duperret E, Lu H, Chan E, Garmezy B, Petrylak D. MP14-19 ARV-766, A PROTAC ANDROGEN RECEPTOR (AR) DEGRADER, COMBINED WITH ABIRATERONE IN NOVEL HORMONAL AGENT (NHA)-NAÏVE METASTATIC PROSTATE CANCER: PHASE 1 COHORT (PART C) OF A PHASE 1/2 STUDY. Journal Of Urology 2024, 211: e227. DOI: 10.1097/01.ju.0001009428.69695.82.19.Peer-Reviewed Original Research